Modi-Mundipharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-12-2024
- Paid Up Capital ₹ 3.00 M
as on 25-12-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 251.75 Cr
as on 25-12-2024
- Satisfied Charges ₹ 198.98 Cr
as on 25-12-2024
- Revenue 19.42%
(FY 2022)
- Profit 265.29%
(FY 2022)
- Ebitda 23.45%
(FY 2022)
- Net Worth 20.37%
(FY 2022)
- Total Assets -2.95%
(FY 2022)
About Modi-Mundipharma
The Corporate was formerly known as Modi-Mundipharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹251.75 Cr. The company has closed loans amounting to ₹198.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Modi-Mundipharma Private Limited India is Sonam Chuni as COMPANY SECRETARY. Abhishek Modi, Bryan Lea, Jayesh Modi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC041928
- Company No.
041928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 1990
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Modi-Mundipharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sonam Chuni | Company Secretary | 01-Jul-2023 | Current |
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhishek Modi | Director | 15-Feb-1995 | Current |
Bryan Lea | Director | 04-Jun-2018 | Current |
Jayesh Modi | Director | 13-Sep-2012 | Current |
Kumkum Modi | Director | 28-Apr-1993 | Current |
Meghna Modi | Director | 25-Mar-1991 | Current |
Umesh Modi | Director | 31-Oct-1990 | Current |
Financial Performance of Modi-Mundipharma.
Modi-Mundipharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.42% increase. The company also saw a substantial improvement in profitability, with a 265.29% increase in profit. The company's net worth Soared by an impressive increase of 20.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Modi-Mundipharma?
In 2022, Modi-Mundipharma had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Modi Industries LimitedActive 92 years 2 months
Abhishek Modi, Jayesh Modi and 2 more are mutual person
- Modi Illva India Private LimitedActive 15 years 7 months
Abhishek Modi and Umesh Modi are mutual person
- Modi Hitech India LimitedActive 41 years 11 months
Abhishek Modi, Jayesh Modi and 2 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 09 Feb 2021 | ₹10.00 Cr | Open |
Hdfc Bank Limited Creation Date: 12 Jul 2017 | ₹16.64 Cr | Open |
Hdfc Bank Limited Creation Date: 12 Jul 2017 | ₹2.10 Cr | Open |
How Many Employees Work at Modi-Mundipharma?
Unlock and access historical data on people associated with Modi-Mundipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Modi-Mundipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modi-Mundipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.